Photograph: Ron Antonelli/Bloomberg

Drugmaker Bristol-Myers Squibb said it bought rights to a mid-stage fibrosis drug and its privately held developer for up to $1.25 billion, boosting i(...)

New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing com(...)

Diageo, which owns Guinness, has been under pressure lately to more closely align its shipments to distributors with their sales to customers

Drinks giant Diageo is under scrutiny in the US, where the Securities and Exchange Commission (SEC) has asked for information to see whether it shippe(...)

A Roche logo sits on a sign outside Roche Holding’s headquarters in Basel, Switzerland.  Photograph: Philipp Schmidli/Bloomberg

Switzerland’s Roche expects no copycat competition to its biotech cancer drugs for another two years, giving it space to grow a successful portfolio o(...)

US stocks rose   as expectations that the Federal Reserve will push any interest rate increases further into the year offset concerns over faltering economic growth spurred by a surprisingly weak jobs report last week. Photograph: Andrew Harrer/Bloomberg

US stocks rose in early trading yesterday as expectations that the Federal Reserve will push any interest rate increases further into the year offset(...)

Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sa(...)

Bristol-Myers Squibb said it would buy drugmaker Flexus Biosciences for up to $1.25 billion to add an emerging class of cancer-fighting drugs to its p(...)

Scott McCauley, associate scientist at the Gilead Sciences, makes human proteins at the Gilead laboratory in Foster City, California. Photograph: David Paul Morris/Bloomberg

Anne Strange was too ill to dance at the evening reception when her daughter, Debbie, married in November but just being there was enough. The 63-year(...)

IDA chief executive Martin Shanahan is “cautiously optimistic” going into 2015. Photograph: Alan Betson/The Irish Times.

IDA Ireland, the State agency responsible for attracting inward investment, said it will publish a new five-year strategy in coming weeks that will pa(...)

Bristol-Myers Squibb chief executive Lamberto Andreotti and Taoiseach Enda Kenny in New York this week.

Bristol-Myers Squibb has a subsidiary in Luxembourg that has one part-time employee, assets of €22.7 billion, and a branch in Swords, Co Dublin. (...)